Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-022024

Chief Financial Officer gave up 2,998 shares (to pay taxes)

  • Chief Financial Officer acquired 9,957 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Tsuchimoto Kim R · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-30 Exercise or conversion : show line 1 in the form +9,957 60,427 D
2024-06-30 Shares withheld for taxes : show line 2 in the form −2,998 $0.73 $2,192 57,429 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −9,957 74,412 D
Loading xslF345X05/rdgdoc.xml…